Damora Therapeutics (DMRA) Other Non-Current Assets (2019 - 2026)

Damora Therapeutics has reported Other Non-Current Assets for 8 years, with the latest figure at $34000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 89.27% year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $34000.0 (down 89.27% YoY), and the FY2025 full-year result was $104000.0, down 36.2% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $34000.0, down from $104000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $3.0 million in Q2 2022, with the low at $34000.0 in Q1 2026.
• Historically, Other Non-Current Assets has averaged $1.6 million across 5 years, with a median of $2.0 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 1320.3% — and 2026, when it sank 89.27%.
• Damora Therapeutics' Other Non-Current Assets stood at $2.3 million in 2022, then slumped by 50.5% to $1.1 million in 2023, then slumped by 85.55% to $163000.0 in 2024, then tumbled by 36.2% to $104000.0 in 2025, then plunged by 67.31% to $34000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $34000.0 (Q1 2026), $104000.0 (Q4 2025), and $837000.0 (Q3 2025), per Business Quant data.